Key facts
- It has raised $11.1M; the latest was Later Stage VC ($8.8M) in Apr 2025.
- Notable investors include Angelini Holding, ENEA Tech Biomedical, Ulixes Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Biovitae
- ·The full record, as it builds
Funding rounds
No funding rounds for Biovitae are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biovitae
Developer of a sanitation and lighting system intended to detox the air and the surfaces of homes. The company's system provides NO-UV light bulbs and a combined LED+photocatalysis technology that eliminates bacteria, viruses, molds, fungi, and spores, enabling users to sanitize environments by reducing bacterial load.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Salerno, Italy
- Founded
- 2015
- Employees
- 9
- Website
- biovitae.it/
- Ownership
- Privately Held (backing)
Biovitae doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biovitae shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biovitae in its N-PORT filings yet. We sweep new filings monthly.